Answers are grounded in this paper and cite their sources.
Retrospective study analyzes diagnostic yield of metagenomic sequencing and blood culture in ICU patients with antibiotic exposure, indicating metagenomic sequencing's superiority.
Background: Blood cultures often yield negative results in critically ill patients, particularly after antimicrobial therapy has started. Plasma metagenomic next-generation sequencing enables culture-independent pathogen detection, but its diagnostic performance relative to blood cultures, especially under ongoing antibiotic exposure in ICU populations, remains unclear. Methods: In this retrospective single-center study, we analyzed adult ICU patients who underwent plasma metagenomic next-generation sequencing testing with paired contemporaneous blood culture between March 2023 and September 2024. Patients were classified according to antibiotic exposure at the time of sampling, and the diagnostic yield and performance of metagenomic next-generation sequencing and blood culture were compared overall and stratified by duration of antibiotic exposure. Results: A total of 393 paired metagenomic next-generation sequencing-blood culture samples from 302 ICU patients were analyzed. Blood culture positivity was significantly lower in patients receiving antibiotics at the time of sampling (10.4% vs. 30.4%), whereas metagenomic next-generation sequencing positivity for bacteria remained stable (52.6% vs. 50.8%). With increasing antibiotic exposure, blood culture yield declined sharply, while metagenomic next-generation sequencing detection showed minimal variation. Overall, the concordance of metagenomic next-generation sequencing compared with blood culture as a comparator was 75.3%, with a negative predictive value of 88.0%. Across all subgroups, metagenomic next-generation sequencing demonstrated a higher diagnostic yield than blood culture, with the greatest relative advantage in antibiotic-treated patients. Conclusions: In critically ill patients receiving antimicrobial therapy, blood culture diagnostic yield is markedly reduced, whereas plasma metagenomic next-generation sequencing maintains pathogen detection across varying durations of antibiotic exposure. Metagenomic next-generation sequencing represents a valuable complementary diagnostic tool alongside blood cultures in pretreated ICU patients.
No takes yet. Share an insight, caveat, or question.
Schroeder et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: